Unformatted text preview: rological diseases, cancer, and AIDS. While it was often the clinical trial itself that gave rise to a question that required new methodology to answer, it is likely that the methods will ﬁnd applications in other medical ﬁelds. In this sense, the contributions are examples of ‘‘ ideal ’’ biostatistics, tran-scending the boundary between statistical theory and clinical trials prac-tice. I wish to express my deep appreciation to all the authors for their patience and collegiality and for their ﬁne contributions and outstanding expositions. I also thank my husband for his constant encouragement and Marcel Dekker, Inc., for their continuing interest in this project. Nancy L. Geller Copyright n 2004 by Marcel Dekker, Inc. All Rights Reserved....
View Full Document
This note was uploaded on 06/13/2011 for the course PHYSICS 101 taught by Professor Shu during the Spring '11 term at FIU.
- Spring '11